Natera reports Q4 results
Source: SeekingAlpha
2026-02-26 16:17:17 ET
More on Natera
- Natera, Inc. (NTRA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- Natera, Inc. (NTRA) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- Why Natera Remains A 'Hold' For Me Despite Surging MRD Growth And Fatter Margins
- Natera Q4 2025 Earnings Preview
- Natera expects a 35% jump in FY revenue
Read the full article on Seeking Alpha
For further details see:
Natera reports Q4 results
Natera Inc.
NASDAQ: NTRA
NTRA Trading
-2.04% G/L:
$193.275 Last:
47,210 Volume:
$193.75 Open:
NTRA Latest News
March 12, 2026 08:00:00 am
MyOme Debuts Zenith(TM) Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026
March 12, 2026 08:00:00 am
Natera Announces Commercial Launch of Zenith(TM) Genomics for Rare Disease Diagnosis
February 28, 2026 04:57:00 am
3 Reasons Exelixis Stock Could Deliver Market?Beating Returns Over the Next Decade
February 27, 2026 10:05:00 am
Signatera(TM) MRD Data at ASCO GU Highlights Potential Utility Across GU Cancers, Including for Bladder Preservation
NTRA Stock Data
$29,241,088,573
130,533,658
0.75%
312
N/A
Medical Diagnostics & Screening
Healthcare
US
Austin
